nyvac-hiv-pt4
Vaccineexperimental
Clinical trial activity
4 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2012 (NCT01799954)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- nyvac-hiv-pt4
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01964937 | Phase 1 | Oct 15, 2013 | EuroVacc Foundation, National Institute of Allergy and Infectious Diseases (NIAID), University of Lausanne, University of Rochester |
| NCT01927835 | Phase 1 | Aug 20, 2013 | Columbia University, EuroVacc Foundation, HIV Vaccine Trials Network, National Institute of Allergy and Infectious Diseases (NIAID), University of Lausanne |
| NCT01783977 | Phase 1 | Apr 1, 2013 | National Institute of Allergy and Infectious Diseases (NIAID), University of Lausanne |
| NCT01799954 | Phase 1 | Aug 1, 2012 | HIV Vaccine Trials Network, University of Lausanne |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Lausanne | Academic/Hospital | 4 | 0 | 1 | 2012 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 3 | 3 | 1 | 2013 |
| EuroVacc Foundation | Academic/Hospital | 2 | 0 | 1 | 2013 |
| HIV Vaccine Trials Network | Academic/Hospital | 2 | 1 | 1 | 2012 |
| Columbia University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| University of Rochester | Academic/Hospital | 1 | 0 | 1 | 2013 |
6 organizations
Page 1 / 1